RA Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Hold |
6,045,351
| – | – | 0.29% | 36 |
|
|
2025
Q1 | $13M | Hold |
6,045,351
| – | – | 0.22% | 59 |
|
|
2024
Q4 | $23.4M | Hold |
6,045,351
| – | – | 0.31% | 54 |
|
|
2024
Q3 | $39.6M | Hold |
6,045,351
| – | – | 0.46% | 43 |
|
|
2024
Q2 | $43.8M | Hold |
6,045,351
| – | – | 0.58% | 43 |
|
|
2024
Q1 | $45.9M | Buy |
+6,045,351
| New | +$45.9M | 0.58% | 43 |
|
|
2022
Q3 | – | Sell |
-1,031,482
| Closed | -$2.02M | – | 90 |
|
|
2022
Q2 | $2.02M | Sell |
1,031,482
-250,378
| -20% | -$491K | 0.05% | 81 |
|
|
2022
Q1 | $5.19M | Sell |
1,281,860
-52,750
| -4% | -$214K | 0.11% | 88 |
|
|
2021
Q4 | $14.4M | Sell |
1,334,610
-180,541
| -12% | -$1.95M | 0.25% | 68 |
|
|
2021
Q3 | $17.5M | Hold |
1,515,151
| – | – | 0.24% | 65 |
|
|
2021
Q2 | $14.9M | Hold |
1,515,151
| – | – | 0.24% | 61 |
|
|
2021
Q1 | $22.1M | Hold |
1,515,151
| – | – | 0.33% | 54 |
|
|
2020
Q4 | $32.4M | Hold |
1,515,151
| – | – | 0.45% | 50 |
|
|
2020
Q3 | $23M | Hold |
1,515,151
| – | – | 0.42% | 46 |
|
|
2020
Q2 | $19.5M | Buy |
+1,515,151
| New | +$19.5M | 0.38% | 41 |
|
|
2015
Q2 | – | Sell |
-61,080
| Closed | -$29M | – | 62 |
|
|
2015
Q1 | $29M | Hold |
61,080
| – | – | 2.88% | 11 |
|
|
2014
Q4 | $22.6M | Hold |
61,080
| – | – | 2.43% | 10 |
|
|
2014
Q3 | $14.4M | Buy |
+61,080
| New | +$14.4M | 1.7% | 15 |
|